Department of Oral and Maxillofacial Surgery, and Plastic Surgery, Gunma University Graduate School of Medicine, 3-39-22, Showamachi, Maebashi, Gunma, 371-8511, Japan.
Department of Diagnostic Radiology and Nuclear Medicine, Gunma University Graduate School of Medicine, 3-39-22, Showamachi, Maebashi, Gunma, 371-8511, Japan.
Support Care Cancer. 2021 Aug;29(8):4277-4284. doi: 10.1007/s00520-020-05909-9. Epub 2021 Jan 7.
Oral adverse events, such as dental inflammation with exacerbation, are stressful and lead to poor nutrition in patients undergoing cancer therapy. Thus, the prediction of risk factors for dental inflammation with exacerbation is important before cancer therapy is initiated. We hypothesized that, during cancer therapy (DIECT), fluorodeoxyglucose-positron emission tomography/computed tomography (FDG-PET/CT) imaging could be useful to predict dental inflammation with exacerbation.
We enrolled 124 patients who underwent FDG-PET/CT for diagnostic staging before cancer treatment. We then assessed DIECT outcomes after basic perioperative oral treatment. Moreover, we evaluated clinical parameters, therapeutic strategies, periodontal examination (probing depth (PD) and bleeding on probing (BOP)), dental imaging, and FDG-PET/CT imaging results of patients with and without DIECT. Furthermore, PET/CT images were assessed as per the FDG accumulation of the dental lesion (PAD) grading system.
Univariate analysis demonstrated significant differences in age, periodontal examination (PD and BOP), and PAD grade between patients with and without DIECT. Furthermore, multivariate logistic regression analysis identified independent predictive factors for a positive periodontal examination (PD) (odds ratio (OR) 5.9, 95% confidence interval (CI) 1.8-19.7; P = 0.004) and PAD grade (OR 11.6, 95% CI 3.2-41.2; P = 0.0002). In patients with cancer, PAD grade using FDG-PET/CT imaging was an independent and informative risk factor for DIECT.
Our results suggested that, for patients with DIECT, periodontal examination and PAD grade were independent predictive factors. Hence, regardless of the presence or absence of any lesion on dental imaging, PAD grade might be an additional tool, in addition to periodontal examination that potentially improves oral care management.
口腔不良反应,如伴加重的牙周炎,会给癌症治疗患者带来压力并导致营养状况不良。因此,在开始癌症治疗前预测伴加重的牙周炎的风险因素非常重要。我们假设,在癌症治疗期间(DIECT),氟脱氧葡萄糖正电子发射断层扫描/计算机断层扫描(FDG-PET/CT)成像可以用于预测伴加重的牙周炎。
我们纳入了 124 名在癌症治疗前接受 FDG-PET/CT 进行诊断分期的患者。然后,我们评估了在基本围手术期口腔治疗后的 DIECT 结果。此外,我们评估了有和无 DIECT 的患者的临床参数、治疗策略、牙周检查(探诊深度(PD)和探诊出血(BOP))、牙科影像学和 FDG-PET/CT 影像学结果。此外,根据牙齿病变的 FDG 摄取(PAD)分级系统评估 PET/CT 图像。
单因素分析显示,有和无 DIECT 的患者在年龄、牙周检查(PD 和 BOP)和 PAD 分级方面存在显著差异。此外,多变量逻辑回归分析确定了牙周检查阳性的独立预测因素(PD)(优势比(OR)5.9,95%置信区间(CI)1.8-19.7;P=0.004)和 PAD 分级(OR 11.6,95%CI 3.2-41.2;P=0.0002)。在癌症患者中,FDG-PET/CT 成像的 PAD 分级是 DIECT 的独立和信息性的危险因素。
我们的结果表明,对于 DIECT 患者,牙周检查和 PAD 分级是独立的预测因素。因此,无论牙齿影像学上是否存在任何病变,PAD 分级可能是一种额外的工具,除了牙周检查外,还可能改善口腔护理管理。